Lawrence M. Alleva - 01 Jun 2021 Form 4 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Role
Director
Signature
/s/ Brian DeSchuytner, as Attorney-in-Fact
Issuer symbol
MRSN
Transactions as of
01 Jun 2021
Net transactions value
+$14,883
Form type
4
Filing time
03 Jun 2021, 18:58:03 UTC
Next filing
15 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRSN Common Stock Purchase $14,883 +1,035 +95% $14.38* 2,120 01 Jun 2021 Held by Trust F1, F2
holding MRSN Common Stock 0 01 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In a Form 4 filed on June 3, 2020, the reporting person reported direct beneficial ownership of 1,085 shares of the Company's common stock. Such shares are held directly by the Lawrence M. Alleva Revocable Trust and the nature of the reporting person's interest in such shares is indirect.
F2 The securities are held directly by the Lawrence M. Alleva Revocable Trust.